Tempus AI Slumps to 92nd in Market Rankings as Trading Volume Drops 20.37 Percent

On June 30, 2025, Tempus AI (TEM) experienced a significant decline, with its trading volume reaching 7.32 billion, marking a 20.37% decrease from the previous day. This placed Tempus at the 92nd position in the daily stock market rankings. The stock price of Tempus AI dropped by 4.48%, marking the second consecutive day of decline, with a total decrease of 7.02% over the past two days.

Tempus AI, Inc. has announced a proposed offering of convertible senior notes worth $400 million, with an additional over-allotment option of up to $60 million. This strategic move aims to optimize the company's capital structure and reduce interest expenses. The offering, set to mature in 2030, will be used to retire a high-cost term loan of $274.7 million, fund capped call transactions to mitigate dilution, and allocate capital toward strategic initiatives.

This restructuring is part of Tempus's broader strategy to scale its AI platform, which integrates genomic and clinical data to personalize cancer treatment. By reducing debt servicing costs, the company can reinvest more capital into research and development, partnerships, and acquisitions, critical for expanding its leadership in liquid biopsy assays and AI-driven diagnostics.

Tempus AI has also announced that investors with substantial losses have the opportunity to lead a class action lawsuit against the company. This development comes as Tempus continues to navigate the complexities of its financial restructuring and strategic initiatives.